Bio Science Animal Health Public Company Limited
Stock Exchange of ThailandTotal Valuation
Bio Science Animal Health Public Company Limited carries a market capitalization of 640.56M, placing it among publicly traded companies globally. Its enterprise value stands at 357.69M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 640.56M |
| Enterprise Value | 357.69M |
Share Statistics
Bio Science Animal Health Public Company Limited currently has 314.00M shares outstanding.
| Shares Outstanding | 314.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Bio Science Animal Health Public Company Limited trades at a trailing price-to-earnings ratio of 16.97. The price-to-sales ratio is 0.29, and the price-to-book ratio stands at 2.34.
| PE Ratio | 16.97 |
| PS Ratio | 0.29 |
| PB Ratio | 2.34 |
| P/TBV Ratio | 0.78 |
| P/FCF Ratio | 2.76 |
| P/OCF Ratio | 2.81 |
Enterprise Valuation
On an enterprise value basis, Bio Science Animal Health Public Company Limited trades at an EV/EBITDA multiple of 4.78 and an EV/FCF ratio of 1.55. The EV/Sales ratio of 0.16 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 6.48 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.16 |
| EV / EBITDA | 4.78 |
| EV / EBIT | 6.48 |
| EV / FCF | 1.55 |
Financial Position
Bio Science Animal Health Public Company Limited maintains a current ratio of 2.67, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.79, indicating moderate leverage, while an interest coverage ratio of 106.31 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.67 |
| Quick Ratio | 1.95 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | 0.09 |
| Interest Coverage | 106.31 |
Financial Efficiency
Bio Science Animal Health Public Company Limited posts a return on equity of 13.35 and a return on invested capital of 5.09.
| Return on Equity (ROE) | 13.35 |
| Return on Assets (ROA) | 3.07 |
| Return on Invested Capital (ROIC) | 5.09 |
| Return on Capital Employed (ROCE) | 10.81 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.18 |
Taxes
Over the trailing twelve months, Bio Science Animal Health Public Company Limited has paid 11.92M in income taxes, reflecting an effective tax rate of 21.86.
| Income Tax | 11.92M |
| Effective Tax Rate | 21.86 |
Stock Price Statistics
Bio Science Animal Health Public Company Limited's stock has declined approximately -17.07317% over the past 52 weeks. The 50-day moving average sits at 2.03, while the 200-day moving average is 2.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | -17.07317% |
| 50-Day Moving Average | 2.03 |
| 200-Day Moving Average | 2.08 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Bio Science Animal Health Public Company Limited generated 2.20B in revenue and converted that into 37.39M in net income, yielding earnings per share of 0.14. EBITDA reached 74.84M, while operating income came in at 55.21M.
| Revenue | 2.20B |
| Gross Profit | 323.33M |
| Operating Income | 55.21M |
| Pretax Income | 54.51M |
| Net Income | 37.39M |
| EBITDA | 74.84M |
| EBIT | 55.21M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
Bio Science Animal Health Public Company Limited holds 297.99M in cash and equivalents against 6.43M in total debt, resulting in a net debt position of -41.58M. Total book value stands at 271.04M, with working capital of 623.13M providing operational flexibility.
| Cash & Cash Equivalents | 297.99M |
| Total Debt | 6.43M |
| Net Debt | -41.58M |
| Equity (Book Value) | 271.04M |
| Book Value Per Share | 0.86 |
| Working Capital | 623.13M |
Cash Flow
Bio Science Animal Health Public Company Limited produced 225.53M in operating cash flow over the past twelve months. After subtracting -4.31M in capital expenditures, free cash flow totaled 221.23M - equivalent to 0.70 per share.
| Operating Cash Flow | 225.53M |
| Capital Expenditures | -4.31M |
| Free Cash Flow | 221.23M |
| FCF Per Share | 0.70 |
Margins
Bio Science Animal Health Public Company Limited operates with a gross margin of 14.69, reflecting its pricing power and cost economics. The operating margin of 2.51 and net profit margin of 1.70 provide insight into operational efficiency.
| Gross Margin | 14.69 |
| Operating Margin | 2.51 |
| Pretax Margin | 2.48 |
| Profit Margin | 1.70 |
| EBITDA Margin | 3.40 |
Dividends & Yields
The company's payout ratio of 111.67 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.17 |
| Dividend Yield | N/A |
| Payout Ratio | 111.67 |
| Shareholder Yield | 9.54 |
| FCF Yield | 36.24 |
Scores
Bio Science Animal Health Public Company Limited posts an Altman Z-Score of 3.73, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.73 |